Shandong Science ›› 2020, Vol. 33 ›› Issue (2): 121-125.doi: 10.3976/j.issn.1002-4026.2020.02.017

• Other Research Article • Previous Articles     Next Articles

Methodology validation for the analysis of genotoxic impurity in erlotinib hydrochloride with liquid chromatography-mass spectrometry

LIU Lan-qi, ZHAO Yan-fang*, XIE Han-yi, WANG Shan-shan, CHEN Xiang-feng   

  1. Shandong Analysis and Test Center,Qilu University of Technology(Shandong Academy of Sciences), Jinan 250014,China
  • Received:2019-10-14 Published:2020-04-20 Online:2020-03-30

Abstract: A method was established for the determination of genotoxic impurity.in erlotinib hydrochloride(3-ethynylaniline) using liquid chromatography-mass spectrometry. Using the ESI ion source positive ion multireaction monitoring (MRM) mode,the ion pairs 118→75 and 118→91 were selected and measured. The chromatographic column was Thermo Hyperiil GOLD C8(100 mm×4.6 mm,3 μm),the mobile phase was methanol and waterfor gradient elution,the flow rate was 0.4 mL/min,and the column temperature is 35℃.Results showed that the detection mass concentration of 3-ethynylaniline in this method had a good linear relationship in the range of 1.0 to 20 ng/mL, with R2=0.999 4.The relative standard deviation(n=6) of the precision experiment was 1.13%,and the recoveries of standard additions (n=3) at low,medium,and high concentrations were between 90.1% and 106.1%.The method exhibited high sensitivity,specificity,and precision,and it met the requirement for the determination of 3-acetyleniline,a genotoxic impurity in erlotinib hydrochloride tablets.

Key words: liquid chromatography-mass spectrometry, erlotinic hydrochloride, 3-acetylene aniline, methodology validation

CLC Number: 

  • O657.34

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits third parties to freely share (i.e., copy and redistribute the material in any medium or format) and adapt (i.e., remix, transform, or build upon the material) the articles published in this journal, provided that appropriate credit is given, a link to the license is provided, and any changes made are indicated. The material may not be used for commercial purposes. For details of the CC BY-NC 4.0 license, please visit: https://creativecommons.org/licenses/by-nc/4.0